Sonodynamically induced cell damage using rose bengal derivative.

Area of Science:

• Biomedical Engineering
• Photochemistry
• Oncology

Background:

• Rose bengal (RB) is a photosensitizer with potential in sonodynamic therapy.
• Tumor-accumulative derivatives of RB may improve targeted drug delivery and efficacy.
• Investigating the sonosensitizing ability of RB derivatives is crucial for therapeutic development.

Purpose of the Study:

• To evaluate the sonosensitizing efficacy of a tumor-accumulative rose bengal derivative (RBD).
• To determine if RBD maintains or enhances the sonodynamic effects of RB on tumor cells.
• To assess the mechanism of cell damage induced by RBD and ultrasound.

Main Methods:

• Sarcoma 180 cells were suspended in phosphate-buffered saline.
• Cells were exposed to ultrasound (standing wave mode) with or without RBD or RB.
• Cell viability was assessed using trypan blue exclusion assay.
• The role of active oxygen species was investigated using scavengers like histidine, tryptophan, and N-acetyl-L-cysteine.

Main Results:

• The ultrasonically induced cell-damaging rate was one order of magnitude higher with 100 μM RBD compared to RB at the same concentration.
• The enhanced cell damage induced by RBD was significantly inhibited by active oxygen scavengers.
• This suggests that the increased efficacy of RBD is mediated by reactive oxygen species.

Conclusions:

• Chemical modification of RB into RBD for tumor accumulation significantly enhances the sonodynamically induced antitumor effect.
• RBD demonstrates superior sonosensitizing ability compared to the parent compound RB.
• The findings support the potential of RBD as an effective agent in sonodynamic cancer therapy.